Exhibit 32.1

STATEMENT OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 1350 OF TITLE 18 OF THE UNITED STATES CODE

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350 of Title 18 of the United States Code as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Jerry Katzman, the Chief Executive Officer of RetinalGenix Technologies Inc. (the “Company”), hereby certify that based on the undersigned’s knowledge:

	1.	The Company’s Annual Report on Form 10-K for the period ended December 31, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 31, 2025	/s/ Jerry Katzman
	Jerry Katzman
	Chief Executive Officer, President and Interim Chief Financial Officer
	(Principal Executive Officer and Principal Financial and Accounting Officer)

RetinalGenix Technologies Inc. 10-K